Assessing Patient Outcomes after Palliative Radiotherapy Using IG-IMRT

DOI: 10.4236/jct.2012.36130   PDF   HTML   XML   3,282 Downloads   5,000 Views  

Abstract

Purpose: To assess clinical outcomes after using IG-IMRT for palliation among patients with advanced cancers. Methods: Patients with advanced and/or metastatic cancers were treated on our Tomo-PAL (Tomotherapy?-Planning and Administration Linked) protocol using helical TomoTherapy? and evaluated to assess clinical efficacy of treatment as well as to assess side effects. Results: A total of 40 patients were treated to 40 sites from Feb 2007 to May 2009. There were 25 men and 15 women with a median age of 70 years (range 16 - 94). Pain and bleeding were the most common symptoms being palliated (80% and 12.5% respectively). The dose prescribed ranged from 5 - 25 Gy in 1 - 5 fractions. A qualitative improvement in symptoms was documented in 82% of patients (75% partial relief and 7% complete relief) and major side effects were not encountered. Conclusions: IG-IMRT can be used for palliation and produces response rates that compare favourably with those reported in the published literature.

Share and Cite:

R. Samant, M. Scopazzi and K. Carty, "Assessing Patient Outcomes after Palliative Radiotherapy Using IG-IMRT," Journal of Cancer Therapy, Vol. 3 No. 6, 2012, pp. 1007-1011. doi: 10.4236/jct.2012.36130.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] J. P. Ciezki, S. Komurcu and R. M. Macklis, “Palliative Radiotherapy,” Seminars in Oncology, Vol. 27, No. 1, 2000, pp. 90-93.
[2] D. Hoegler, “Radiotherapy for Palliation of Symptoms in Incurable Cancer,” Current Problems in Cancer, Vol. 21, No. 3, 1997, pp. 129-183. doi:10.1016/S0147-0272(97)80004-9
[3] M. Ashby, “The Role of Radiotherapy in Palliative Care,” Journal of Pain and Symptom Management, Vol. 6, No. 6, 1991, pp. 380-388. doi:10.1016/0885-3924(91)90030-8
[4] G. Stevens and I. Firth, “Clinical Audit in Radiation Oncology: Results from One Centre,” Australasian Radiology, Vol. 40, No. 1, 1996, pp. 47-54. doi:10.1111/j.1440-1673.1996.tb00345.x
[5] M. V. Williams, N. D. James, E. T. Summers, A. Barrett and D. V. Ash, “On Behalf of the Audit Sub-Committee, Faculty of Clinical Oncology and the Royal College of Radiologists National Survey of Radiotherapy Fractionation Practice in 2003,” Clinical Oncology (Royal College of Radiologists), Vol. 18, No. 1, 2006, pp. 3-14. doi:10.1016/j.clon.2005.10.002
[6] R. Andrade, et al., “A Simple and Effective Daily Pain Management Method for Patients Receiving Radiation Therapy for Painful Bone Metastasis,” International Journal of Radiation Oncology*Biology*Physics, Vol. 78, No. 3, 2010, pp. 855-859.
[7] L. Vakeat and T. Boterberg, “Pain Control by Ionizing Radiation of Bone Metastasis,” International Journal of Developmental Biology, Vol. 48, No. 5-6, 2004, pp. 599-606. doi:10.1387/ijdb.041817lv
[8] M. Van den Beuken-van Everdingen, et al., “Prevalence of Pain in Patients with Cancer: A Systematic Review of the past 40 Years,” Annals of Oncology, Vol. 18, No. 9, 2007, pp. 1437-1449. doi:10.1093/annonc/mdm056
[9] R. Samant and A. C. Gooi, “Radiotherapy Basics for Family Physicians: Potent Tool for Symptom Relief,” Canadian Family Physician, Vol. 51, No. 11, 2005, pp. 1496-1501.
[10] A. Konski, S. Feigenberg and E. Chow, “Palliative Radiation Therapy,” Seminars in Oncology, Vol. 32, No. 2, 2005, pp. 156-164. doi:10.1053/j.seminoncol.2004.11.013
[11] M. MacPherson, et al., “On-Line Rapid Palliation Using Helical Tomotherapy: A Prospective Feasibility Study,” Radiotherapy and Oncology, Vol. 87, No. 1, 2008, pp. 116-118. doi:10.1016/j.radonc.2008.01.017
[12] R. Samant, L. Gerig, L. Montgomery, R. Macrae, et al., “High-Technology Palliative Radiotherapy Using Image-Guided Intensity-Modulated Radiotherapy,” Clinical Oncology (Royal College of Radiologists), Vol. 20, No. 9, 2008, pp. 718-720. doi:10.1016/j.clon.2008.08.002
[13] R. Samant, L. Gerig, L. Montgomery, R. Macrae, et al., “The Emerging Role of IG-IMRT for Palliative Radiotherapy: A Single-Institution Experience,” Current Oncology, Vol. 16, No. 3, 2009, pp. 40-45.
[14] I. Lee, et al., “Early Clinical Experience and Outcome of Helical Tomotherapy for Multiple Metastatic Lesions,” International Journal of Radiation Oncology*Biology* Physics, Vol. 73, No. 5, 2009, pp. 1517-1524.
[15] S. Ryu, et al., “Pain Control by Image-Guided Radiosurgery for Solitary Spinal Metastasis,” Journal of Pain and Symptom Management, Vol. 35, No. 3, 2008, pp. 292-298. doi:10.1016/j.jpainsymman.2007.04.020
[16] J. Sheehan, et al., “Radiosurgery in the Treatment of Spinal Metastases: Tumour Control, Survival, and Quality of Life after Helical Tomotherapy,” Neurosurgery, Vol. 65, No. 6, 2009, pp. 1052-1062. doi:10.1227/01.NEU.0000359315.20268.73
[17] S. Lutz, S. S. Lo, E. Chow, A. Sahgal and P. Hoskin, “Radiotherapy for Metastatic Bone Disease: Current Standards and Future Prospectus,” Expert Review of Anticancer Therapy, Vol. 10, No. 5, 2010, pp. 683-695. doi:10.1586/era.10.32
[18] J. Baisden, et al., “Helical Tomotherapy in the Treatment of Central Nervous System Metastasis,” Neurosurgery Focus, Vol. 22, No. 3, 2007, pp. 1-6. doi:10.3171/foc.2007.22.3.9

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.